KalVista Pharmaceuticals, Inc. short interest in 2019
In 2019, KalVista Pharmaceuticals, Inc.'s disclosed short interest ran from 4.63% of shares outstanding on 15 Oct 2019 to 4.92% on 31 Dec 2019, a change of +0.29 percentage points. The year's high was 4.92% on 31 Dec 2019 and its low 4.12% on 31 Oct 2019, averaging 4.49% across 6 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 9.81 days on 31 Dec 2019. Full history: KalVista Pharmaceuticals, Inc..
Cite this page
By year: 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2019 in figures
- Start of year
- 4.63% (15 Oct 2019)
- End of year
- 4.92% (31 Dec 2019)
- Change
- +0.29 pp
- High
- 4.92% (31 Dec 2019)
- Low
- 4.12% (31 Oct 2019)
- Average
- 4.49%
- Highest days to cover
- 9.81 (31 Dec 2019)
- SEC filings marked
- 8
Every report in 2019
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 15 Oct 2019 | 4.63% | 3.18 | 10-Q filed, results (8-K), 10-K filed, results (8-K), 10-Q filed, results (8-K) |
| 31 Oct 2019 | 4.12% | 6.93 | |
| 15 Nov 2019 | 4.16% | 7.96 | |
| 29 Nov 2019 | 4.67% | 5.50 | |
| 13 Dec 2019 | 4.42% | 3.13 | 10-Q filed, results (8-K) |
| 31 Dec 2019 | 4.92% | 9.81 |
See also: KalVista Pharmaceuticals, Inc.'s full history · most shorted US stocks of 2019 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.